+Compare
OGN
Stock ticker: NYSE
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
4.67B

OGN Price Prediction, Organon & Co AI Recommendations

Stock market charts, price targets, analyst ratings and a financial calendar

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
a Summary for OGN with price predictions
08:00 PM EDT Sep 21, 2023

OGN's Stochastic Oscillator stays in oversold zone for 12 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where OGN advanced for three days, in of 125 cases, the price rose further within the following month. The odds of a continued upward trend are .

OGN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 22, 2023. You may want to consider selling the stock, shorting the stock, or exploring put options on OGN as a result. In of 34 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for OGN turned negative on August 18, 2023. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 14 similar instances when the indicator turned negative. In of the 14 cases the stock turned lower in the days that followed. This puts the odds of success at .

OGN moved below its 50-day moving average on September 05, 2023 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for OGN crossed bearishly below the 50-day moving average on September 08, 2023. This indicates that the trend has shifted lower and could be considered a sell signal. In of 7 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where OGN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for OGN entered a downward trend on September 22, 2023. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (6.139). OGN has a moderately low P/E Ratio (6.188) as compared to the industry average of (31.865). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.317). OGN's Dividend Yield (0.061) is considerably higher than the industry average of (0.028). OGN's P/S Ratio (0.757) is slightly lower than the industry average of (3.735).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. OGN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OGN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 68, placing this stock worse than average.

A.I. Advisor
published Earnings

OGN is expected to report earnings to fall 17.56% to $1.08 per share on November 09

Organon & Co OGN Stock Earnings Reports
Q3'23
Est.
$1.08
Q2'23
Beat
by $0.34
Q1'23
Missed
by $0.07
Q4'22
Missed
by $0.11
Q3'22
Beat
by $0.23
The last earnings report on August 08 showed earnings per share of $1.31, beating the estimate of 97 cents. With 3.09M shares outstanding, the current market capitalization sits at 4.67B.
A.I.Advisor
published Dividends

OGN paid dividends on September 14, 2023

Organon & Co OGN Stock Dividends
А dividend of $0.28 per share was paid with a record date of September 14, 2023, and an ex-dividend date of August 17, 2023. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), ABBVIE (NYSE:ABBV), AstraZeneca PLC (NASDAQ:AZN), Pfizer (NYSE:PFE), Amgen (NASDAQ:AMGN), Bristol-Myers Squibb Co (NYSE:BMY), Gilead Sciences (NASDAQ:GILD), Biogen (NASDAQ:BIIB).

Industry description

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

Market Cap

The average market capitalization across the Pharmaceuticals: Major Industry is 80.43B. The market cap for tickers in the group ranges from 72.83K to 522.62B. LLY holds the highest valuation in this group at 522.62B. The lowest valued company is CRXTQ at 72.83K.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Major Industry was -2%. For the same Industry, the average monthly price growth was -3%, and the average quarterly price growth was -0%. MIRA experienced the highest price growth at 39%, while SCLX experienced the biggest fall at -30%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Major Industry was -52%. For the same stocks of the Industry, the average monthly volume growth was -60% and the average quarterly volume growth was 4%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 28
P/E Growth Rating: 59
Price Growth Rating: 57
SMR Rating: 57
Profit Risk Rating: 67
Seasonality Score: -21 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
N/A
Address
30 Hudson Street
Phone
+1 551 430-6900
Employees
10000
Web
https://www.organon.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PSIL1.660.04
+2.41%
AdvisorShares Psychedelics ETF
IAUF57.540.15
+0.26%
iShares Gold Strategy ETF
BKLN21.03N/A
N/A
Invesco Senior Loan ETF
VFMF102.37-0.18
-0.18%
Vanguard US Multifactor ETF
TMFC39.46-0.10
-0.25%
Motley Fool 100 ETF

OGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, OGN has been loosely correlated with AZN. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if OGN jumps, then AZN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OGN
1D Price
Change %
OGN100%
-1.72%
AZN - OGN
34%
Loosely correlated
+1.21%
PFE - OGN
32%
Poorly correlated
-0.49%
GRFS - OGN
32%
Poorly correlated
+0.32%
JNJ - OGN
30%
Poorly correlated
-0.72%
GILD - OGN
29%
Poorly correlated
-0.35%
More